TABLE OF CONTENTS
Volume 41, Issue 6 (March (2) 2008)
Review
Autologous graft-versus-host disease: harnessing anti-tumor immunity through impaired self-tolerance FREE
J Kline, S Subbiah, H M Lazarus and K van Besien
Bone Marrow Transplant 41: 505-513; advance online publication, November 19, 2007; doi:10.1038/sj.bmt.1705931
Original Articles
Cell Procurement
Functional analysis of cytomegalovirus-specific T lymphocytes compared to tetramer assay in patients undergoing hematopoietic stem cell transplantation FREE
Y Morita-Hoshi, Y Heike, M Kawakami, T Sugita, O Miura, S-W Kim, S-I Mori, T Fukuda, R Tanosaki, K Tobinai and Y Takaue
Bone Marrow Transplant 41: 515-521; advance online publication, November 19, 2007; doi:10.1038/sj.bmt.1705932
Cord Blood Stem Cells
Preinfusion variables predict the predominant unit in the setting of reduced-intensity double cord blood transplantation FREE
R L Haspel, G Kao, B Y Yeap, C Cutler, R J Soiffer, E P Alyea, V T Ho, J Koreth, B R Dey, S L McAfee, E C Attar, T Spitzer, J H Antin and K K Ballen
Bone Marrow Transplant 41: 523-529; advance online publication, November 26, 2007; doi:10.1038/sj.bmt.1705933
Pediatric Transplants
Combination of enzyme replacement and hematopoietic stem cell transplantation as therapy for Hurler syndrome FREE
J Tolar, S S Grewal, K J Bjoraker, C B Whitley, E G Shapiro, L Charnas and P J Orchard
Bone Marrow Transplant 41: 531-535; advance online publication, November 26, 2007; doi:10.1038/sj.bmt.1705934
Allografting
Allogeneic hematopoietic cell transplantation for metastatic breast cancer FREE
N T Ueno, J D Rizzo, T Demirer, Y C Cheng, U Hegenbart, M-J Zhang, M Bregni, A Carella, D Blaise, A Bashey, J D Bitran, B J Bolwell, G J Elfenbein, K K Fields, C O Freytes, R P Gale, H M Lazarus, R E Champlin, P J Stiff and D Niederwieser
Bone Marrow Transplant 41: 537-545; advance online publication, December 17, 2007; doi:10.1038/sj.bmt.1705940
Autografting
High-dose melphalan and autologous stem cell transplantation as consolidation treatment in patients with chemosensitive ovarian cancer: results of a single-institution randomized trial FREE
C Papadimitriou, U Dafni, A Anagnostopoulos, G Vlachos, Z Voulgaris, A Rodolakis, G Aravantinos, A Bamias, G Bozas, E Kiosses, G M Gourgoulis, E Efstathiou and M A Dimopoulos
Bone Marrow Transplant 41: 547-554; advance online publication, November 19, 2007; doi:10.1038/sj.bmt.1705925
Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer FREE
P Biron, M Durand, H Roché, T Delozier, C Battista, P Fargeot, D Spaeth, T Bachelot, E Poiget, F Monnot, M L Tanguy and H Curé
Bone Marrow Transplant 41: 555-562; advance online publication, November 26, 2007; doi:10.1038/sj.bmt.1705935
Stem cell-derived cardiomyocytes after bone marrow and heart transplantation FREE
R A de Weger, I Verbrugge, A H Bruggink, M M van Oosterhout, Y de Souza, D F van Wichen, F H J Gmelig-Meyling, N de Jonge and L F Verdonck
Bone Marrow Transplant 41: 563-569; advance online publication, November 26, 2007; doi:10.1038/sj.bmt.1705939
Graft-versus-Host Disease
Low-dose MTX for the treatment of acute and chronic graft-versus-host disease in children FREE
J Inagaki, Y Nagatoshi, M Hatano, N Isomura, M Sakiyama and J Okamura
Bone Marrow Transplant 41: 571-577; advance online publication, November 19, 2007; doi:10.1038/sj.bmt.1705922
Pre-Clinical Studies
In vitro and in vivo evaluation of the haematopoietic potential of skeletal muscle in a non-human primate model FREE
C Haond, M Drouet, S Derdouch, M-L Bonnet, F Norol, J-F Mayol, W Vainchenker, R LeGrand, A G Turhan and F Herodin
Bone Marrow Transplant 41: 579-584; advance online publication, November 26, 2007; doi:10.1038/sj.bmt.1705941
Letters to the Editor
Heparin toxicity following allogeneic bone marrow infusion FREE
M J Williamson Jr, G C Kudva and S M Pincus
Bone Marrow Transplant 41: 585-586; advance online publication, November 19, 2007; doi:10.1038/sj.bmt.1705936
Chimerism does not predict for outcome after alemtuzumab-based conditioning: lineage-specific analysis of chimerism of specific diseases may be more informative FREE
Z Y Lim, L Pearce, W Ingram, A Y L Ho, G J Mufti and A Pagliuca
Bone Marrow Transplant 41: 587-588; advance online publication, November 26, 2007; doi:10.1038/sj.bmt.1705937
Comparison of peripheral blood and bone marrow samples for detection of post transplant mixed chimerism FREE
J Stumph, C L Vnencak-Jones, T Koyama and H Frangoul
Bone Marrow Transplant 41: 589-590; advance online publication, November 26, 2007; doi:10.1038/sj.bmt.1705938
Durable remission of large B-cell lymphoma transformed from lymphoplasmacytic lymphoma/Waldenström macroglobulinemia successfully treated with sequential immunochemotherapy followed by reduced-intensity allogeneic stem cell transplantation FREE
R Yamamoto, A Takaori-Kondo, J Kanda, K Imada, T Ichinohe, T Ishikawa, K Ohmori and T Uchiyama
Bone Marrow Transplant 41: 591-593; advance online publication, December 10, 2007; doi:10.1038/sj.bmt.1705944
Successful therapy of chronic graft-versus-host disease manifesting as pure red cell aplasia with single-agent rituximab FREE
D M Benson Jr, M K Smith, D Krugh and S M Devine
Bone Marrow Transplant 41: 595-596; advance online publication, November 26, 2007; doi:10.1038/sj.bmt.1705945
